Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation

被引:236
作者
Grotendorst, GR [1 ]
Rahmanie, H [1 ]
Duncan, MR [1 ]
机构
[1] Univ Miami, Sch Med, Dept Cell Biol & Anat, RMSB 2030 A, Miami, FL 33136 USA
关键词
myofibroblasts; TGF-beta; CTGF; fibrotic tissue;
D O I
10.1096/fj.03-0699com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fibroblast proliferation, differentiation into myofibroblasts, and increased collagen synthesis are key events during both normal wound repair and fibrotic lesion formation. Here we report that these biological responses to TGF-beta by fibroblasts are regulated via a CTGF-dependent pathway in concert with either EGF or IGF-2. Our studies indicate these responses to TGF-beta are mutually exclusive, and cells that are proliferating do not express alpha-SMA or elevated levels of collagen synthesis. Cells expressing alpha-SMA do not exhibit DNA synthesis but do coexpress higher levels of types I and III collagen mRNA. Thus, fibroblast proliferation and differentiation are controlled by combinatorial signaling pathways involving not only components of the TGF-beta/CTGF pathway, but also signaling events induced by EGF and IGF-2-activated receptors. Collectively, our studies indicate TGF-beta functions as a classic embryonic inducer, initiating a cascade that is controlled by other factors in the cellular environment. We propose a model for this process with regard to wound repair and fibrotic lesion formation that is likely applicable to other instances of CTGF action during embryogenesis.
引用
收藏
页码:469 / 479
页数:11
相关论文
共 73 条
[1]  
[Anonymous], 2002, World Health Report, 2002: Reducing risks, promoting healthy life
[2]   SARCOMA GROWTH-FACTOR FROM CONDITIONED MEDIUM OF VIRALLY TRANSFORMED-CELLS IS COMPOSED OF BOTH TYPE-ALPHA AND TYPE-BETA TRANSFORMING GROWTH-FACTORS [J].
ANZANO, MA ;
ROBERTS, AB ;
SMITH, JM ;
SPORN, MB ;
DELARCO, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (20) :6264-6268
[3]  
ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155
[4]  
ASSOIAN RK, 1984, CELL, V36, P35, DOI 10.1016/0092-8674(84)90071-0
[5]  
Badid C, 2000, HISTOL HISTOPATHOL, V15, P269, DOI 10.14670/HH-15.269
[6]   SERUM-FREE CELL-CULTURE - A UNIFYING APPROACH [J].
BARNES, D ;
SATO, G .
CELL, 1980, 22 (03) :649-655
[7]   Evidence that TGF-β should he a therapeutic target in diabetic nephropathy [J].
Border, WA ;
Noble, NA .
KIDNEY INTERNATIONAL, 1998, 54 (04) :1390-1391
[8]   THE MODULAR ARCHITECTURE OF A NEW FAMILY OF GROWTH-REGULATORS RELATED TO CONNECTIVE-TISSUE GROWTH-FACTOR [J].
BORK, P .
FEBS LETTERS, 1993, 327 (02) :125-130
[9]   CONNECTIVE-TISSUE GROWTH-FACTOR - A CYSTEINE-RICH MITOGEN SECRETED BY HUMAN VASCULAR ENDOTHELIAL-CELLS IS RELATED TO THE SRC-INDUCED IMMEDIATE EARLY GENE-PRODUCT CEF-10 [J].
BRADHAM, DM ;
IGARASHI, A ;
POTTER, RL ;
GROTENDORST, GR .
JOURNAL OF CELL BIOLOGY, 1991, 114 (06) :1285-1294
[10]   TRANSFORMING GROWTH-FACTOR BETA-1 SUPPRESSES ACUTE AND CHRONIC ARTHRITIS IN EXPERIMENTAL-ANIMALS [J].
BRANDES, ME ;
ALLEN, JB ;
OGAWA, Y ;
WAHL, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) :1108-1113